Login to Your Account

Appointments and advancements

Wednesday, February 5, 2014

Novogen Ltd., of Sydney, named Justine Stehn director of the anti-tropomyosin (ATM) program, and appointed Peter Gunning to its scientific advisory panel for ATM technology.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription